A clinical study of plasma homocysteine levels in chronic kidney disease at a tertiary care center

M. Vinay Kumar; Vithal Rao; Sayed Mohammed Meraj Hussaini; Azhar Thouseef Baig T.

doi:10.18203/2320-6012.ijrms20253172

Authors

M. Vinay Kumar Department of General Medicine, Al-Ameen Medical College and Hospital, Vijayapura, Karnataka, India
Vithal Rao Department of General Medicine, Al-Ameen Medical College and Hospital, Vijayapura, Karnataka, India
Sayed Mohammed Meraj Hussaini Department of General Medicine, Al-Ameen Medical College and Hospital, Vijayapura, Karnataka, India
Azhar Thouseef Baig T. Department of General Medicine, Al-Ameen Medical College and Hospital, Vijayapura, Karnataka, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20253172

Keywords:

Cardiovascular risk, Chronic kidney disease, Glomerular filtration rate, Homocysteine, Renal function

Abstract

Background: Chronic kidney disease (CKD) is associated with progressive loss of renal function and elevated plasma homocysteine levels, which may increase cardiovascular risk. This study aimed to assess the association between renal function decline and homocysteine levels in CKD patients.

Methods: A single-center, prospective observational study was conducted over 18 months involving 50 CKD patients. Demographic, clinical, and biochemical data including plasma homocysteine, serum creatinine, blood urea nitrogen (BUN), urea, glomerular filtration rate (GFR), and albumin levels were collected. Patients were stratified by homocysteine levels (normal <15 µmol/l, elevated >15 µmol/l), and associations with renal parameters were analyzed.

Results: Elevated homocysteine was observed in 38 (76%) patients. Patients with elevated homocysteine had significantly higher plasma homocysteine levels (21.98±7.52 µmol/l) compared to the normal group (12.22±1.83 µmol/l, p=0.001). Serum creatinine was higher in the elevated group (8.30±4.68 mg/dl) versus normal (4.68±2.17 mg/dl, p=0.001). Similarly, BUN (57.89±15.41 mg/dl versus 42.18±6.22 mg/dl, p=0.001) and urea (121.58±32.37 mg/dl versus 88.58±13.06 mg/dl, p=0.001) were elevated. The mean GFR was significantly lower in the elevated homocysteine group (11.68±6.30 ml/minute) compared to the normal group (16.44±7.93 ml/minute, p=0.03). Significant correlations were found between homocysteine and serum creatinine (r=0.305, p=0.03), BUN (r=0.335, p=0.01), urea (r=0.345, p=0.01), and GFR (r= -0.412, p=0.01).

Conclusions: Elevated homocysteine levels may serve as a useful biomarker and potential therapeutic target to mitigate cardiovascular risk and disease progression in CKD.

Metrics

Metrics Loading ...

References

Evans M, Lewis RD, Morgan AR, Whyte MB, Hanif W, Bain SC, et al. A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther. 2022;39(1):33-43. DOI: https://doi.org/10.1007/s12325-021-01927-z

Slee AD. Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab. 2012;9(1):36. DOI: https://doi.org/10.1186/1743-7075-9-36

Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SN. The metabolism and significance of homocysteine in nutrition and health. Nutr Metab. 2017;14(1):78. DOI: https://doi.org/10.1186/s12986-017-0233-z

Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Investig. 2001;81(5):645-72. DOI: https://doi.org/10.1038/labinvest.3780275

Levi A, Cohen E, Levi M, Goldberg E, Garty M, Krause I. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study. Eur J Intern Med. 2014;25(10):951-5. DOI: https://doi.org/10.1016/j.ejim.2014.10.014

Shih YL, Shih CC, Chen JY. Elevated homocysteine level as an indicator for chronic kidney disease in community-dwelling middle-aged and elderly populations in Taiwan: a community-based cross-sectional study. Front Med. 2022;9:964101. DOI: https://doi.org/10.3389/fmed.2022.964101

Chen W, Feng J, Ji P, Liu Y, Wan H, Zhang J. Association of hyperhomocysteinemia and chronic kidney disease in the general population: a systematic review and meta-analysis. BMC Nephrol. 2023;24(1):247. DOI: https://doi.org/10.1186/s12882-023-03295-y

Al Mutairi F. An insight to hyperhomocysteinemia in CKD patients of a tertiary care hospital, Karachi. J Coll Phys Surg Pak. 2025;35(35):180-4. DOI: https://doi.org/10.29271/jcpsp.2025.02.180

Yadav V, Prakash V, Fiza B, Sinha M. Study of serum homocysteine level in patients with chronic kidney disease and its association with renal function and serum albumin. Int J Res Med Sci. 2020;8(6):2195-8. DOI: https://doi.org/10.18203/2320-6012.ijrms20202265

Patel M, Bidri RC. Estimation of plasma homocysteine level in chronic kidney disease patients with and without dialysis. Int J Acad Med Pharm. 2024;6(6):29-33.

Song JH, Huh H, Bae E, Lee J, Lee JP, Lee JS, et al. Association between homocysteinemia and mortality in CKD: a propensity-score matched analysis using NHANES-National Death Index. Medicine. 2022;101(36):e30334. DOI: https://doi.org/10.1097/MD.0000000000030334

Clarke R, Lewington S, Landray M. Homocysteine, renal function, and risk of cardiovascular disease. Kidney Int. 2003;63:S131-3. DOI: https://doi.org/10.1046/j.1523-1755.63.s84.7.x

Long Y, Nie J. Homocysteine in renal injury. Kidney Dis. 2016;2(2):80-7. DOI: https://doi.org/10.1159/000444900

Yang Q, Lu Y, Deng Y, Xu J, Zhang X. Homocysteine level is positively and independently associated with serum creatinine and urea nitrogen levels in old male patients with hypertension. Sci Rep. 2020;10(1):18050. DOI: https://doi.org/10.1038/s41598-020-75073-x

Sadaria RG, Vasava SN, Gosai D. Estimation of serum homocysteine and lipid profile in chronic kidney disease patients. Int J Health Sci. 2022;6(S5):5476-82. DOI: https://doi.org/10.53730/ijhs.v6nS5.11136

Cheng T, Wang X, Han Y, Hao J, Hu H, Hao L. The level of serum albumin is associated with renal prognosis and renal function decline in patients with chronic kidney disease. BMC Nephrol. 2023;24(1):57. DOI: https://doi.org/10.1186/s12882-023-03110-8

Xie D, Yuan Y, Guo J, Yang S, Xu X, Wang Q, et al. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults. Sci Rep. 2015;5:16268. DOI: https://doi.org/10.1038/srep16268

Kumar V, Gulati Y, Giri R, Babulal VRK, Varma P, Kala C. Correlation of serum homocysteine with HbA1c and kidney function in type 2 diabetic patients: insights from estimated glomerular filtration rate and renal impairment. Int J Res Med Sci. 2024;13(1):235-40. DOI: https://doi.org/10.18203/2320-6012.ijrms20244121

Dhoat PS, Nayyar SB, Kaur G. Study of Correlation between Serum Homocysteine Levels and Albuminuria in Type 2 Diabetes Mellitus. Int J Med Res Proff. 2019;62(3):62-6.